Product Code: PMRREP3774
Global Injectable Drug Delivery Market: Scope of the Report
The latest publication by Persistence Market Research on the global injectable drug delivery market evaluates the opportunities and current market landscape, provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for injectable drug delivery market and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the injectable drug delivery market. Shareholders in the injectable drug delivery market, industry experts, investors, researchers, and reporters, as well as business enthusiasts can leverage insights and information presented in this Persistence Market Research study.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the injectable drug delivery market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research's study on the injectable drug delivery market offers information divided into six important segments - product, technology, usage, indication, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Product
Self-Injectors
Single Chamber Self Injectors
Dual Chamber Self Injectors
Needle Free Injectors
Pre Filled Needle Free Injectors
Fill-Able Needle free Injectors
Auto Injectors
Prefilled Auto Injectors
Fill-Able Auto Injectors
Wearable Injectors
Wearable Patch Injectors
Off-body Worn Injectors
Insulin Pens
Reusable Insulin Pens
Disposable Insulin Pens
Smart Insulin Pens
Technology
Non-Smart Injectors
Smart Injectors
Artificial Intelligence (AI) and Machine Learning Integrated
Near Filed Communication (NFC)
Cloud Computing
Bluetooth
Usage
Disposable Injectors
Reusable Injectors
Indication
Anaphylaxis
Diabetes
Cardiovascular Diseases
Multiple Sclerosis
Rheumatoid Arthritis
Cancer
Trauma and Emergency
Others
Distribution Channel
Hospital Pharmacies
Drug Stores
Retail Pharmacies
Online Pharmacies
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa (MEA)
Key Questions Answered in Report:
Which regions will continue to remain the most profitable markets for injectable drug delivery in the coming years?
How will changing trends influence the market?
How has the COVID-19 crisis influenced market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will influence the market?
How can companies in the injectable drug delivery market avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the injectable drug delivery market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research's projections on the growth prospects of the injectable drug delivery market are more accurate and reliable.
Table of Contents
1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand Side Trends
- 1.3. Supply Side Trends
- 1.4. Analysis and Recommendations
2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 2.3. Inclusions & Exclusions
3. Key Market Trends
- 3.1. Key Trends Impacting the Market
- 3.2. Product Innovation / Development Trends
4. Key Success Factors
- 4.1. Product Adoption Analysis
- 4.2. Key Strategies, by Market Players
- 4.3. PESTLE Analysis
- 4.4. Porter's Analysis
- 4.5. Disease Epidemiology
- 4.6. Key Regulations
- 4.7. Supply Chain Analysis
- 4.8. Parenteral Drugs Pipeline Assessment
5. Market Background
- 5.1. Macro-Economic Factors
- 5.1.1. GDP Growth Outlook
- 5.1.2. Healthcare Industry Market Outlook
- 5.1.3. Global Drug Delivery Industry Overview
- 5.1.4. R&D Expenditure Outlook
- 5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Top Companies Historical Growth
- 5.2.2. New/Improved Product Launches
- 5.2.3. Growing Geriatric Population
- 5.2.4. Prevalence of Diabetes
- 5.2.5. Technological Advancements
- 5.2.6. Mergers and Acquistions
- 5.2.7. Strategic Collaborations
- 5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
- 6.1. COVID-19 Impact Analysis
- 6.1.1. By Product
- 6.1.2. By Technology
- 6.1.3. By Usage
- 6.1.4. By Indication
- 6.1.5. By Distribution Channel
- 6.2. 2021 Market Scenario
7. Global Injectable Drug Delivery Market (in Value or Size in US$ Mn) Analysis 2014-2022 and Forecast, 2023-2033
- 7.1. Historical Market Value (US$ Mn) Analysis, 2014-2022
- 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis
8. Global Injectable Drug Delivery Market Analysis 2014-2022 and Forecast 2023-2033, by Product
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2014-2022
- 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product 2023-2033
- 8.3.1. Self Injector
- 8.3.1.1. Single Chamber Self Injector
- 8.3.1.2. Dual Chamber Self Injector
- 8.3.2. Needle Free Injectors
- 8.3.2.1. Pre-Filled Needle Free Injectors
- 8.3.2.2. Fill-Able Needle Free Injecors
- 8.3.3. Auto Injectors
- 8.3.3.1. Pre-Filled Auto Injector
- 8.3.3.2. Fill-Able Auto Injector
- 8.3.4. Wearable Injectors
- 8.3.4.1. Wearable Patch Injectors
- 8.3.4.2. Off-body Worn Injectors
- 8.3.5. Insulin Pens
- 8.3.5.1. Reusable Insulin Pens
- 8.3.5.2. Disposable Insulin Pens
- 8.3.5.3. Smart Insulin Pens
- 8.4. Market Attractiveness Analysis By Product
9. Global Injectable Drug Delivery Market Analysis 2014-2022 and Forecast 2023-2033, by Technology
- 9.1. Introduction / Key Findings
- 9.2. Historical Market Size (US$ Mn) Analysis By Technology, 2014-2022
- 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2023-2033
- 9.3.1. Non-Smart Injectors
- 9.3.2. Smart Injectors
- 9.3.2.1. Artificial Intelligence (AI) & Machine Learning Integrated
- 9.3.2.2. Near Field Communication(NFR)
- 9.3.2.3. Cloud Computing
- 9.3.2.4. Bluetooth
- 9.4. Market Attractiveness Analysis By Technology
10. Global Injectable Drug Delivery Market Analysis 2014-2022 and Forecast 2023-2033, by Usage
- 10.1. Introduction / Key Findings
- 10.2. Historical Market Size (US$ Mn) Analysis By Usage, 2014-2022
- 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Usage, 2023-2033
- 10.3.1. Disposable Injectors
- 10.3.2. Reusable Injectors
- 10.4. Market Attractiveness Analysis By Usage
11. Global Injectable Drug Delivery Market Analysis 2014-2022 and Forecast 2023-2033, by Indication
- 11.1. Introduction / Key Findings
- 11.2. Historical Market Size (US$ Mn) Analysis By Indication, 2014-2022
- 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2023-2033
- 11.3.1. Anaphylaxis
- 11.3.2. Diabetes
- 11.3.3. Cardiovascular Diseases
- 11.3.4. Multiple Sclerosis
- 11.3.5. Rheumatoid Arthritis
- 11.3.6. Cancer
- 11.3.7. Others
- 11.4. Market Attractiveness Analysis By Indication
12. Global Injectable Drug Delivery Market Analysis 2014-2022 and Forecast 2023-2033, by Distribution Channel
- 12.1. Introduction / Key Findings
- 12.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2022
- 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2023-2033
- 12.3.1. Hospital Pharmacies
- 12.3.2. Drug Stores
- 12.3.3. Retail Pharmacies
- 12.3.4. Online Pharmacies
- 12.4. Market Attractiveness Analysis By Distribution Channel
13. Global Injectable Drug Delivery Market Analysis 2014-2022 and Forecast 2023-2033, by Region
- 13.1. Introduction
- 13.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2022
- 13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2023-2033
- 13.3.1. North America
- 13.3.2. Latin America
- 13.3.3. Europe
- 13.3.4. South Asia
- 13.3.5. East Asia
- 13.3.6. Oceania
- 13.3.7. Middle East and Africa
- 13.4. Market Attractiveness Analysis By Region
14. North America Global Injectable Drug Delivery Market Analysis 2014-2022 and Forecast 2023-2033
- 14.1. Introduction
- 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2022
- 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023-2033
- 14.3.1. By Country
- 14.3.1.1. U.S.
- 14.3.1.2. Canada
- 14.3.2. By Product
- 14.3.3. By Technology
- 14.3.4. By Usage
- 14.3.5. By Indication
- 14.3.6. By Distribution Channel
- 14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Product
- 14.4.3. By Technology
- 14.4.4. By Usage
- 14.4.5. By Indication
- 14.4.6. By Distribution Channel
- 14.5. Country Level Analysis & Forecast
- 14.5.1. U.S. Injectable Drug Delivery Market
- 14.5.1.1. Introduction
- 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 14.5.1.2.1. By Product
- 14.5.1.2.2. By Technology
- 14.5.1.2.3. By Usage
- 14.5.1.2.4. By Indication
- 14.5.1.2.5. By Distribution Channel
- 14.5.2. Canada Injectable Drug Delivery Market
- 14.5.2.1. Introduction
- 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 14.5.2.2.1. By Product
- 14.5.2.2.2. By Technology
- 14.5.2.2.3. By Usage
- 14.5.2.2.4. By Indication
- 14.5.2.2.5. By Distribution Channel
- 14.6. Drivers and Restraints - Impact Analysis
15. Latin America Injectable Drug Delivery Market Analysis 2014-2022 and Forecast 2023-2033
- 15.1. Introduction
- 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022
- 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033
- 15.3.1. By Country
- 15.3.1.1. Brazil
- 15.3.1.2. Mexico
- 15.3.1.3. Argentina
- 15.3.1.4. Rest of Latin America
- 15.3.2. By Product
- 15.3.3. By Technology
- 15.3.4. By Usage
- 15.3.5. By Indication
- 15.3.6. By Distribution Channel
- 15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Product
- 15.4.3. By Technology
- 15.4.4. By Usage
- 15.4.5. By Indication
- 15.4.6. By Distribution Channel
- 15.5. Country Level Analysis & Forecast
- 15.5.1. Brazil Injectable Drug Delivery Market Analysis
- 15.5.1.1. Introduction
- 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 15.5.1.2.1. By Product
- 15.5.1.2.2. By Technology
- 15.5.1.2.3. By Usage
- 15.5.1.2.4. By Indication
- 15.5.1.2.5. By Distribution Channel
- 15.5.2. Mexico Injectable Drug Delivery Market Analysis
- 15.5.2.1. Introduction
- 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 15.5.2.2.1. By Product
- 15.5.2.2.2. By Technology
- 15.5.2.2.3. By Usage
- 15.5.2.2.4. By Indication
- 15.5.2.2.5. By Distribution Channel
- 15.5.3. Argentina Injectable Drug Delivery Market Analysis
- 15.5.3.1. Introduction
- 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
- 15.5.3.2.1. By Product
- 15.5.3.2.2. By Technology
- 15.5.3.2.3. By Usage
- 15.5.3.2.4. By Indication
- 15.5.3.2.5. By Distribution Channel
- 15.6. Drivers and Restraints - Impact Analysis
16. Europe Global Injectable Drug Delivery Market Analysis 2014-2022 and Forecast 2023-2033
- 16.1. Introduction
- 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2022
- 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023-2033
- 16.3.1. By Country
- 16.3.1.1. Germany
- 16.3.1.2. Italy
- 16.3.1.3. France
- 16.3.1.4. U.K.
- 16.3.1.5. Spain
- 16.3.1.6. BENELUX
- 16.3.1.7. Russia
- 16.3.1.8. Nordic Countries
- 16.3.1.9. Rest of Europe
- 16.3.2. By Product
- 16.3.3. By Technology
- 16.3.4. By Usage
- 16.3.5. By Indication
- 16.3.6. By Distribution Channel
- 16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Product
- 16.4.3. By Technology
- 16.4.4. By Usage
- 16.4.5. By Indication
- 16.4.6. By Distribution Channel
- 16.5. Country Level Analysis & Forecast
- 16.5.1. Germany Injectable Drug Delivery Market
- 16.5.1.1. Introduction
- 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.1.2.1. By Product
- 16.5.1.2.2. By Technology
- 16.5.1.2.3. By Usage
- 16.5.1.2.4. By Indication
- 16.5.1.2.5. By Distribution Channel
- 16.5.2. Italy Injectable Drug Delivery Market
- 16.5.2.1. Introduction
- 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.2.2.1. By Product
- 16.5.2.2.2. By Technology
- 16.5.2.2.3. By Usage
- 16.5.2.2.4. By Indication
- 16.5.2.2.5. By Distribution Channel
- 16.5.3. France Injectable Drug Delivery Market
- 16.5.3.1. Introduction
- 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.3.2.1. By Product
- 16.5.3.2.2. By Technology
- 16.5.3.2.3. By Usage
- 16.5.3.2.4. By Indication
- 16.5.3.2.5. By Distribution Channel
- 16.5.4. U.K. Global Injectable Drug Delivery Market
- 16.5.4.1. Introduction
- 16.5.4.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.4.2.1. By Product
- 16.5.4.2.2. By Technology
- 16.5.4.2.3. By Usage
- 16.5.4.2.4. By Indication
- 16.5.4.2.5. By Distribution Channel
- 16.5.5. Spain Injectable Drug Delivery Market
- 16.5.5.1. .Introduction
- 16.5.5.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.5.2.1. By Product
- 16.5.5.2.2. By Technology
- 16.5.5.2.3. By Usage
- 16.5.5.2.4. By Indication
- 16.5.5.2.5. By Distribution Channel
- 16.5.6. BENELUX Injectable Drug Delivery Market
- 16.5.6.1. .Introduction
- 16.5.6.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.6.2.1. By Product
- 16.5.6.2.2. By Technology
- 16.5.6.2.3. By Usage
- 16.5.6.2.4. By Indication
- 16.5.6.2.5. By Distribution Channel
- 16.5.7. Russia Injectable Drug Delivery Market
- 16.5.7.1. .Introduction
- 16.5.7.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.7.2.1. By Product
- 16.5.7.2.2. By Technology
- 16.5.7.2.3. By Usage
- 16.5.7.2.4. By Indication
- 16.5.7.2.5. By Distribution Channel
- 16.5.8. Nordic Countries Injectable Drug Delivery Market
- 16.5.8.1. .Introduction
- 16.5.8.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.8.2.1. By Product
- 16.5.8.2.2. By Technology
- 16.5.8.2.3. By Usage
- 16.5.8.2.4. By Indication
- 16.5.8.2.5. By Distribution Channel
- 16.6. Drivers and Restraints - Impact Analysis
17. South Asia Injectable Drug Delivery Market Analysis 2014-2022 and Forecast 2023-2033
- 17.1. Introduction
- 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022
- 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033
- 17.3.1. By Country
- 17.3.1.1. India
- 17.3.1.2. Thailand
- 17.3.1.3. Indonesia
- 17.3.1.4. Malaysia
- 17.3.1.5. Rest of South Asia
- 17.3.2. By Product
- 17.3.3. By Technology
- 17.3.4. By Usage
- 17.3.5. By Indication
- 17.3.6. By Distribution Channel
- 17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product
- 17.4.3. By Technology
- 17.4.4. By Usage
- 17.4.5. By Indication
- 17.4.6. By Distribution Channel
- 17.5. Country Level Analysis & Forecast
- 17.5.1. India Injectable Drug Delivery Market Analysis
- 17.5.1.1. Introduction
- 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 17.5.1.2.1. By Product
- 17.5.1.2.2. By Technology
- 17.5.1.2.3. By Usage
- 17.5.1.2.4. By Indication
- 17.5.1.2.5. By Distribution Channel
- 17.5.2. Thailand Injectable Drug Delivery Market Analysis
- 17.5.2.1. .Introduction
- 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 17.5.2.2.1. By Product
- 17.5.2.2.2. By Technology
- 17.5.2.2.3. By Usage
- 17.5.2.2.4. By Indication
- 17.5.2.2.5. By Distribution Channel
- 17.5.3. Indonesia Injectable Drug Delivery Market Analysis
- 17.5.3.1. Introduction
- 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
- 17.5.3.2.1. By Product
- 17.5.3.2.2. By Technology
- 17.5.3.2.3. By Usage
- 17.5.3.2.4. By Indication
- 17.5.3.2.5. By Distribution Channel
- 17.5.4. Malaysia Injectable Drug Delivery Market Analysis
- 17.5.4.1. Introduction
- 17.5.4.2. Market Analysis and Forecast by Market Taxonomy
- 17.5.4.2.1. By Product
- 17.5.4.2.2. By Technology
- 17.5.4.2.3. By Usage
- 17.5.4.2.4. By Indication
- 17.5.4.2.5. By Distribution Channel
- 17.6. Drivers and Restraints - Impact Analysis
18. East Asia Injectable Drug Delivery Market Analysis 2014-2022 and Forecast 2023-2033
- 18.1. Introduction
- 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022
- 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033
- 18.3.1. By Country
- 18.3.1.1. China
- 18.3.1.2. Japan
- 18.3.1.3. South Korea
- 18.3.2. By Product
- 18.3.3. By Technology
- 18.3.4. By Usage
- 18.3.5. By Indication
- 18.3.6. By Distribution Channel
- 18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Product
- 18.4.3. By Technology
- 18.4.4. By Usage
- 18.4.5. By Indication
- 18.4.6. By Distribution Channel
- 18.5. Country Level Analysis & Forecast
- 18.5.1. China Injectable Drug Delivery Market Analysis
- 18.5.1.1. Introduction
- 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 18.5.1.2.1. By Product
- 18.5.1.2.2. By Technology
- 18.5.1.2.3. By Usage
- 18.5.1.2.4. By Indication
- 18.5.1.2.5. By Distribution Channel
- 18.5.2. Japan Injectable Drug Delivery Market Analysis
- 18.5.2.1. Introduction
- 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 18.5.2.2.1. By Product
- 18.5.2.2.2. By Technology
- 18.5.2.2.3. By Usage
- 18.5.2.2.4. By Indication
- 18.5.2.2.5. By Distribution Channel
- 18.5.3. South Korea Injectable Drug Delivery Market Analysis
- 18.5.3.1. Introduction
- 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
- 18.5.3.2.1. By Product
- 18.5.3.2.2. By Technology
- 18.5.3.2.3. By Usage
- 18.5.3.2.4. By Indication
- 18.5.3.2.5. By Distribution Channel
- 18.6. Drivers and Restraints - Impact Analysis
19. Oceania Injectable Drug Delivery Market Analysis 2014-2022 and Forecast 2023-2033
- 19.1. Introduction
- 19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022
- 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033
- 19.3.1. By Country
- 19.3.1.1. Australia
- 19.3.1.2. New Zealand
- 19.3.2. By Product
- 19.3.3. By Technology
- 19.3.4. By Usage
- 19.3.5. By Indication
- 19.3.6. By Distribution Channel
- 19.4. Market Attractiveness Analysis
- 19.4.1. By Country
- 19.4.2. By Product
- 19.4.3. By Technology
- 19.4.4. By Usage
- 19.4.5. By Indication
- 19.4.6. By Distribution Channel
- 19.5. Country Level Analysis & Forecast
- 19.5.1. Australia Injectable Drug Delivery Market Analysis
- 19.5.1.1. Introduction
- 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 19.5.1.2.1. By Product
- 19.5.1.2.2. By Technology
- 19.5.1.2.3. By Usage
- 19.5.1.2.4. By Indication
- 19.5.1.2.5. By Distribution Channel
- 19.5.2. New Zealand Injectable Drug Delivery Market Analysis
- 19.5.2.1. Introduction
- 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 19.5.2.2.1. By Product
- 19.5.2.2.2. By Technology
- 19.5.2.2.3. By Usage
- 19.5.2.2.4. By Indication
- 19.5.2.2.5. By Distribution Channel
- 19.6. Drivers and Restraints - Impact Analysis
20. Middle East and Africa Injectable Drug Delivery Market Analysis 2014-2022 and Forecast 2023-2033
- 20.1. Introduction
- 20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022
- 20.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033
- 20.3.1. By Country
- 20.3.1.1. GCC Countries
- 20.3.1.2. Turkey
- 20.3.1.3. North Africa
- 20.3.1.4. South Africa
- 20.3.1.5. Rest of Middle East and Africa
- 20.3.2. By Product
- 20.3.3. By Technology
- 20.3.4. By Usage
- 20.3.5. By Indication
- 20.3.6. By Distribution Channel
- 20.4. Market Attractiveness Analysis
- 20.4.1. By Country
- 20.4.2. By Product
- 20.4.3. By Technology
- 20.4.4. By Usage
- 20.4.5. By Indication
- 20.4.6. By Distribution Channel
- 20.5. Country Level Analysis & Forecast
- 20.5.1. GCC Countries Injectable Drug Delivery Market Analysis
- 20.5.1.1. Introduction
- 20.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 20.5.1.2.1. By Product
- 20.5.1.2.2. By Technology
- 20.5.1.2.3. By Usage
- 20.5.1.2.4. By Indication
- 20.5.1.2.5. By Distribution Channel
- 20.5.2. Turkey Injectable Drug Delivery Market Analysis
- 20.5.2.1. Introduction
- 20.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 20.5.2.2.1. By Product
- 20.5.2.2.2. By Technology
- 20.5.2.2.3. By Usage
- 20.5.2.2.4. By Indication
- 20.5.2.2.5. By Distribution Channel
- 20.5.3. North Africa Injectable Drug Delivery Market Analysis
- 20.5.3.1. Introduction
- 20.5.3.2. Market Analysis and Forecast by Market Taxonomy
- 20.5.3.2.1. By Product
- 20.5.3.2.2. By Technology
- 20.5.3.2.3. By Usage
- 20.5.3.2.4. By Indication
- 20.5.3.2.5. By Distribution Channel
- 20.5.4. South Africa Injectable Drug Delivery Market Analysis
- 20.5.4.1. Introduction
- 20.5.4.2. Market Analysis and Forecast by Market Taxonomy
- 20.5.4.2.1. By Product
- 20.5.4.2.2. By Technology
- 20.5.4.2.3. By Usage
- 20.5.4.2.4. By Indication
- 20.5.4.2.5. By Distribution Channel
- 20.6. Drivers and Restraints - Impact Analysis
21. Market Structure Analysis
- 21.1. Market Analysis by Tier of Companies
- 21.2. Market Share Analysis of Top Players
- 21.3. Market Presence Analysis
22. Competition Analysis
- 22.1. Competition Dashboard
- 22.2. Competition Deep Dive
- 22.2.1. Eli Lilly and Company
- 22.2.1.1. Overview
- 22.2.1.2. Product Portfolio
- 22.2.1.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.1.4. Sales Footprint
- 22.2.1.5. Strategy Overview
- 22.2.2. Biocon
- 22.2.2.1. Overview
- 22.2.2.2. Product Portfolio
- 22.2.2.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.2.4. Sales Footprint
- 22.2.2.5. Strategy Overview
- 22.2.3. Becton, Dickinson & Company
- 22.2.3.1. Overview
- 22.2.3.2. Product Portfolio
- 22.2.3.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.3.4. Sales Footprint
- 22.2.3.5. Strategy Overview
- 22.2.4. West Pharmaceutical Services, Inc.
- 22.2.4.1. Overview
- 22.2.4.2. Product Portfolio
- 22.2.4.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.4.4. Sales Footprint
- 22.2.4.5. Strategy Overview
- 22.2.5. Johnson & Johnson
- 22.2.5.1. Overview
- 22.2.5.2. Product Portfolio
- 22.2.5.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.5.4. Sales Footprint
- 22.2.5.5. Strategy Overview
- 22.2.6. Antares Pharma
- 22.2.6.1. Overview
- 22.2.6.2. Product Portfolio
- 22.2.6.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.6.4. Sales Footprint
- 22.2.6.5. Strategy Overview
- 22.2.7. AbbVie Inc
- 22.2.7.1. Overview
- 22.2.7.2. Product Portfolio
- 22.2.7.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.7.4. Sales Footprint
- 22.2.7.5. Strategy Overview
- 22.2.8. Pfizer Inc.
- 22.2.8.1. Overview
- 22.2.8.2. Product Portfolio
- 22.2.8.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.8.4. Sales Footprint
- 22.2.8.5. Strategy Overview
- 22.2.9. Mylan N.V.
- 22.2.9.1. Overview
- 22.2.9.2. Product Portfolio
- 22.2.9.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.9.4. Sales Footprint
- 22.2.9.5. Strategy Overview
- 22.2.10. Vetter Pharma-Fertigung GmbH & Co.KG
- 22.2.10.1. Overview
- 22.2.10.2. Product Portfolio
- 22.2.10.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.10.4. Sales Footprint
- 22.2.10.5. Strategy Overview
- 22.2.11. Emperra GmbH
- 22.2.11.1. Overview
- 22.2.11.2. Product Portfolio
- 22.2.11.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.11.4. Sales Footprint
- 22.2.11.5. Strategy Overview
- 22.2.12. Digital Medics Pty Ltd
- 22.2.12.1. Overview
- 22.2.12.2. Product Portfolio
- 22.2.12.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.12.4. Sales Footprint
- 22.2.12.5. Strategy Overview
- 22.2.13. Enable Injections LLC
- 22.2.13.1. Overview
- 22.2.13.2. Product Portfolio
- 22.2.13.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.13.4. Sales Footprint
- 22.2.13.5. Strategy Overview
- 22.2.14. Insulet corporation
- 22.2.14.1. Overview
- 22.2.14.2. Product Portfolio
- 22.2.14.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.14.4. Sales Footprint
- 22.2.14.5. Strategy Overview
- 22.2.15. Consort Medical Plc
- 22.2.15.1. Overview
- 22.2.15.2. Product Portfolio
- 22.2.15.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.15.4. Sales Footprint
- 22.2.15.5. Strategy Overview
- 22.2.16. Diabnext
- 22.2.16.1. Overview
- 22.2.16.2. Product Portfolio
- 22.2.16.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.16.4. Sales Footprint
- 22.2.16.5. Strategy Overview
- 22.2.17. Diamesco Co., Ltd
- 22.2.17.1. Overview
- 22.2.17.2. Product Portfolio
- 22.2.17.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.17.4. Sales Footprint
- 22.2.17.5. Strategy Overview
- 22.2.18. SCHOTT AG
- 22.2.18.1. Overview
- 22.2.18.2. Product Portfolio
- 22.2.18.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.18.4. Sales Footprint
- 22.2.18.5. Strategy Overview
- 22.2.19. SiO2 Medical Products
- 22.2.19.1. Overview
- 22.2.19.2. Product Portfolio
- 22.2.19.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.19.4. Sales Footprint
- 22.2.19.5. Strategy Overview
- 22.2.20. Integrity Bio, Inc.
- 22.2.20.1. Overview
- 22.2.20.2. Product Portfolio
- 22.2.20.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.20.4. Sales Footprint
- 22.2.20.5. Strategy Overview
- 22.2.21. Wilhelm Haselmeier GmbH & Co. KG
- 22.2.21.1. Overview
- 22.2.21.2. Product Portfolio
- 22.2.21.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.21.4. Sales Footprint
- 22.2.21.5. Strategy Overview
- 22.2.22. Tandem Diabetes Care
- 22.2.22.1. Overview
- 22.2.22.2. Product Portfolio
- 22.2.22.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.22.4. Sales Footprint
- 22.2.22.5. Strategy Overview
- 22.2.23. Sanofi S.A.
- 22.2.23.1. Overview
- 22.2.23.2. Product Portfolio
- 22.2.23.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.23.4. Sales Footprint
- 22.2.23.5. Strategy Overview
- 22.2.24. Companion Medical Inc.
- 22.2.24.1. Overview
- 22.2.24.2. Product Portfolio
- 22.2.24.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.24.4. Sales Footprint
- 22.2.24.5. Strategy Overview
- 22.2.25. Ypsomed
- 22.2.25.1. Overview
- 22.2.25.2. Product Portfolio
- 22.2.25.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.25.4. Sales Footprint
- 22.2.25.5. Strategy Overview
- 22.2.26. F.Hoffman - La Roche Ltd.
- 22.2.26.1. Overview
- 22.2.26.2. Product Portfolio
- 22.2.26.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.26.4. Sales Footprint
- 22.2.26.5. Strategy Overview
- 22.2.27. Novo Nordisk A/S
- 22.2.27.1. Overview
- 22.2.27.2. Product Portfolio
- 22.2.27.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.27.4. Sales Footprint
- 22.2.27.5. Strategy Overview
- 22.2.28. Medtronic Plc.
- 22.2.28.1. Overview
- 22.2.28.2. Product Portfolio
- 22.2.28.3. Profitability by Market Segments (Product/Channel/Region)
- 22.2.28.4. Sales Footprint
- 22.2.28.5. Strategy Overview
23. Assumptions and Acronyms Used
24. Research Methodology